Document:

f10q0708ex10ii_previns.htm

    

    SECURITIES
PURCHASE AGREEMENT

    

    THIS SECURITIES PURCHASE
AGREEMENT (this “Agreement”) is made effective the 29th day of August,
2008 by and between, Prevention Insurance.com, Inc., a Nevada corporation (the
“Company”) and Paragon Capital LP, a Delaware limited partnership
(“Paragon”).

    

    RECITAL

    

    WHEREAS, Paragon is willing to
advance the Company twenty thousand dollars ($20,000) for corporate purposes,
and the Company is willing to issue warrants exercisable into shares of common
stock.

    

    AGREEMENT

    

    NOW, THEREFORE, in
consideration of the foregoing recital and the mutual promises hereinafter set
forth, and, other good and valuable consideration, the parties hereto agree as
follows:

    

    

        1.    Issuance of Warrants
Paragon hereby agrees to advance to the Company $20,000 (the “Advance”) for the
purpose of paying administrative expenses including making required filings with
the SEC and paying other legal expenses.  The Company will execute a
warrant agreement (the “Warrant”) which is attached.

    

        2.    Authorization

     

        (a)   Corporate
Action  All corporate action on the part of the Company necessary for
the sale of the warrants and warrant shares upon exercise of the Warrant and the
performance of the Company's actions
hereunder will be taken by the Company at the appropriate time prior to
exercise. This Agreement constitutes a valid and legally binding obligation of
the Company, enforceable in accordance with its terms.

     

        (b)   Valid
Issuance  Upon an exercise, the warrant shares, when
transferred in compliance with the provisions of this Agreement will be duly
authorized, validly issued, fully paid and non-assessable, and will be free of
any liens or encumbrances caused or created by the Company.  This
transaction is deemed to be an arms length transaction.

     

        (c)   No Preemptive Rights
Except as provided herein, no person currently has or will have any right of
first refusal or any preemptive rights in connection with the transfer of the
warrant shares upon an exercise, or any future issuance of securities by the
Company.

     

        3.    All notices,
requests and instructions hereunder shall be in writing and delivered to each
party as may from time to time be designated by a party hereto.

    

        4.    In the event
that any term, covenant, condition, or other provision contained herein is held
to be invalid, void or otherwise unenforceable by any court of competent
jurisdiction, the invalidity of any such term, covenant, condition, provision or
agreement shall in no way
affect any other term, covenant, condition or provision or agreement contained
herein, which shall remain in full force and effect.

     

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    

        5.    This
Agreement contains all of the terms agreed upon by the parties with respect to
the subject matter hereof.  This Agreement has been entered into after
full investigation.

    

        6.    This
Agreement shall be construed in accordance with and governed by the laws of the
State of New York applicable to agreements made and to be performed within the
State of New York without giving the effect to the conflict of law principals
thereof.

    

        7.    No amendments
or additions to this Agreement shall be binding unless in writing, signed by
both parties, except as herein otherwise provided.

     

    Please
sign below to acknowledge the acceptance of the terms of this
Agreement.

     

    
      	      
              PARAGON
      CAPITAL LP    

              

              By:___________________________   

                   
      ALAN DONENFELD

                   
      Managing Member of Paragon Capital Advisors LLC,

                   
      General Partner of Paragon Capital LP

            	
              PREVENTION
      INSURANCE.COM, INC.

               

              By:
_________________________

            

    

     

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    

    EXHIBIT
1

    

    NEITHER
THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE
SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES
LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED
(I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL, IN A
GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR
(II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT.
NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH
A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE
SECURITIES.

    

    PREVENTION
INSURANCE.COM, INC.

    

    Warrant
to Purchase Common Stock

    

    Warrant
No.: A-2

    Number of
Shares of Common Stock: 20,000,000

    Date of
Issuance: August 29, 2008

    

             PREVENTION
INSURANCE.COM, INC., a Nevada corporation (the "Company"), hereby certifies
that, for $20,000, the receipt and sufficiency of which are hereby acknowledged,
Paragon Capital LP and/or its affiliates and/or designees, the registered holder
hereof or its permitted assigns (the "Holder"), is entitled, subject to the
terms set forth below, to purchase from the Company, at the Exercise Price (as
defined below) then in effect, upon surrender of this Warrant, to purchase
Common Stock (including any warrants to Purchase Common Stock issued in
exchange, transfer or replacement hereof, the "Warrant"), at any time or times
on or after the date hereof, but not after 11:59 p.m., New York time, on the
Expiration Date (as defined below), 20,000,000 fully paid nonassessable shares
of Common Stock (as defined below) (the "Warrant Shares"). Except as otherwise
defined herein, capitalized terms in this Warrant shall have the meanings set
forth in Section 17. This Warrant is the Warrant to purchase Common Stock issued
pursuant to a Consulting Agreement dated as of August 29, 2008 (the "Closing
Date"), by and between the Company and the Holder (the
"Agreement").

    

             Section
1. Exercise of Warrant.

     

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    

                (a)
Mechanics of Exercise. Subject to the terms and conditions hereof (including,
without limitation, the limitations set forth in Section 1(f)), this Warrant may
be exercised by the Holder on any day on or after the date hereof, in whole or
in part, by (i) delivery of a written notice, in the form attached hereto as
Exhibit A (the "Exercise Notice"), of the Holder's election to exercise this
Warrant and (ii) (A) payment to the Company of an  amount equal to the
applicable Exercise Price multiplied by the number of Warrant Shares as to which
this Warrant is being exercised (the "Aggregate Exercise Price") in cash or wire
transfer of immediately available funds or (B) by notifying the Company that
this Warrant is being exercised pursuant to a Cashless Exercise (as defined in
Section 1(d)). The Holder shall not be required to deliver the original Warrant
in order to effect an exercise hereunder. Execution and delivery of the Exercise
Notice with respect to less than all of the Warrant Shares shall have the same
effect as cancellation of the original Warrant and issuance of a new
Warrant evidencing the right to purchase the remaining number of Warrant Shares.
On or before the first Business Day following the date on which the Company has
received each of the Exercise Notice and the Aggregate Exercise Price (or notice
of a Cashless
Exercise) (the "Exercise Delivery Documents"), the Company shall transmit an
acknowledgment of confirmation of receipt of the Exercise Delivery Documents to
the Holder and the Company's transfer agent (the "Transfer Agent"). On or before
the third Business Day following the date on which the Company has received all
of the Exercise Delivery Documents, the Company shall (X) issue and deliver to
the address specified in the Exercise Notice, a certificate, registered in the
name of the holder of this Warrant or its designee, for the number of
shares of Common Stock to which the holder of this Warrant is entitled pursuant
to such exercise, or (Y) provided that the Transfer Agent is participating in
the Depository Trust Company ("DTC") Fast Automated Securities Transfer Program,
upon the request of the Holder, credit such aggregate number of shares of Common
Stock to which the Holder is entitled pursuant to such exercise to the Holder's
or its designee's balance account with DTC through its Deposit Withdrawal Agent
Commission system. Upon delivery of the Exercise Notice and Aggregate Exercise
Price referred to in clause (ii)(A) above or notification to the Company of a
Cashless Exercise referred to in Section 1(d), the Holder shall be deemed for
all corporate purposes to have become the holder of record of the Warrant Shares
with respect to which this Warrant has been exercised, irrespective of the date
of delivery of the certificates evidencing such Warrant Shares. If this Warrant
is submitted in connection with any exercise pursuant to this Section 1(a)
and the number of Warrant Shares represented by this Warrant submitted for
exercise is greater than the number of Warrant Shares being acquired upon an
exercise, then the Company shall as soon as practicable and in no event later
than three Business Days after any exercise and at its own expense, issue a new
Warrant (in accordance with Section 8(d)) representing the right to purchase the
number of Warrant Shares purchasable immediately prior to such exercise
under this Warrant, less the number of Warrant Shares with respect to which this
Warrant is exercised. No fractional shares of Common Stock are to be issued upon
the exercise of this Warrant, but rather the number of shares of Common Stock to
be issued shall be rounded up to the nearest whole number. The Company shall pay
any and all taxes which may be payable with respect to the issuance and delivery
of Warrant Shares upon exercise of this Warrant.

    

                (b)
Exercise Price. For purposes of this Warrant, "Exercise Price" means $0.01,
subject to adjustment as provided herein.

    

                (c)
Company's Failure to Timely Deliver Securities. If the Company shall fail for
any reason or for no reason to issue to the Holder within three Business Days of
receipt of the Exercise Delivery Documents, a certificate for the number of
shares of Common Stock to which the Holder is entitled and register such shares
of Common Stock on the Company's share register or to credit the
Holder's balance account with DTC for such number of shares of Common Stock
to which the Holder is entitled upon the Holder's exercise of
this  Warrant, and if on or after such Business Day the Holder
purchases (in an open market transaction or otherwise) shares of Common Stock to
deliver in satisfaction of a sale by the Holder of shares of Common Stock
issuable upon such exercise that the Holder anticipated receiving from the
Company, then the Company shall, within three Business Days after the Holder's
request and in the Holder's discretion, either (i) pay cash to the Holder in an
amount equal to the Holder's total purchase price (including brokerage
commissions, if any) for the shares of Common Stock so purchased (the "Buy-In
Price"), at which point the Company's obligation to deliver such
certificate (and to issue such shares of Common Stock) shall terminate, or (ii)
promptly honor its obligation to deliver to the Holder a certificate or
certificates representing such shares of Common Stock and pay cash to the Holder
in an amount equal to the excess (if any) of the Buy-In Price over the product
of (A) such number of shares of Common Stock, times (B) the Closing Bid Price on
the date of exercise.

    

                (d)
Cashless Exercise. Notwithstanding anything contained herein to the contrary,
the Holder may, in its sole discretion, exercise this Warrant in whole or in
part and, in lieu of making the cash payment otherwise contemplated to be made
to the Company upon such exercise in payment of the Aggregate Exercise Price (a
"Cash Exercise"), elect instead to receive upon such exercise the "Net Number"
of shares of Common Stock determined according to the following formula (a
"Cashless Exercise"):

     

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    

                                                (A
x B) - (A x C)

        Net
Number =
              -------------------------

                                                           B

    

                   For
purposes of the foregoing formula:

    

                         A
= the total number of Warrant Shares with respect to which this Warrant is then
being exercised.

    

                         B
= the Closing Sale Price of the shares of Common Stock (as reported by
Bloomberg) on the date immediately preceding the date of the Exercise
Notice.

    

                         C
= the Exercise Price then in effect for the applicable Warrant Shares at the
time of such exercise.

    

                (e)
Disputes. In the case of a dispute as to the determination of the Exercise Price
or the arithmetic calculation of the Warrant Shares, the Company shall promptly
issue to the Holder the number of Warrant Shares that are not disputed and
resolve such dispute in accordance with Section 14.

    

                (f)
Limitations on Exercise; Beneficial Ownership. The Holder shall not have any
restriction on exercise of this Warrant.

    

             Section
2. Adjustment of Exercise Price and Number of Warrant Shares. The Exercise Price
and the number of Warrant Shares shall be adjusted from time to time as
follows:

    

                (a)
Adjustment upon Issuance of shares of Common Stock. If and whenever on or after
the Closing Date the Company issues or sells, or in accordance with this Section
2 is deemed to have issued or sold, any shares of Common Stock (including the
issuance or sale of shares of Common Stock owned or held by or for the account
of the Company, but excluding shares of Common Stock deemed to have been issued
or sold by the Company in connection with any Excluded Security) for a
consideration per share (the "New Issuance Price") less than a price (the
"Applicable Price") equal to the Exercise Price in effect immediately prior to
such issue or sale or deemed issuance or sale (the foregoing a "Dilutive
Issuance"), then immediately after such Dilutive Issuance, the Exercise Price
then in effect shall be reduced to an amount equal to the New Issuance Price.
Upon each such adjustment of the Exercise Price hereunder, the number of Warrant
Shares shall be adjusted to the number of shares of Common Stock determined by
multiplying the Exercise Price in effect immediately prior to such adjustment by
the number of Warrant Shares acquirable upon exercise of this Warrant
immediately prior to such adjustment and dividing the product thereof by the
Exercise Price resulting from such adjustment. For purposes of determining the
adjusted Exercise Price under this Section 2(a), the following shall be
applicable:

    

                         (i)
Issuance of Options. If the Company in any manner grants any Options and the
lowest price per share for which one share of Common Stock is issuable upon the
exercise of any such Option or upon conversion, exercise or exchange of any
Convertible Securities issuable upon exercise of any such Option is less than
the Applicable Price, then such share of Common Stock shall be deemed to be
outstanding and to have been issued and sold by the Company at the time of the
granting or sale of such Option for such price per share. For purposes of this
Section 2(a)(i), the "lowest price per share for which one share of Common Stock
is issuable upon exercise of such Options or upon conversion, exercise or
exchange of such Convertible Securities" shall be equal to the sum of the lowest
amounts of consideration (if any) received or receivable by the Company with
respect to any one share of Common Stock upon the granting or sale of the
Option, upon exercise of the Option and upon conversion, exercise or exchange of
any
Convertible Security issuable upon exercise of such Option. No further
adjustment of the Exercise Price shall be made upon the actual issuance of such
shares of Common Stock or of such Convertible Securities upon the exercise of
such Options or upon the actual issuance of such shares of Common Stock upon
conversion, exercise or exchange of such Convertible Securities.

     

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    

                         (ii)
Issuance of Convertible Securities. If the Company in any manner issues or sells
any Convertible Securities and the lowest price per share for which one share of
Common Stock is issuable upon the conversion, exercise or exchange thereof is
less than the Applicable Price, then such share of Common Stock shall be deemed
to be outstanding and to have been issued and sold by the Company at the time of
the issuance or sale of such Convertible Securities for such price per share.
For the purposes of this Section 2(a)(ii), the "lowest price per share for which
one share of Common Stock is issuable upon the conversion, exercise or exchange"
shall be equal to the sum of the lowest amounts of consideration (if any)
received or receivable by the Company with respect to one share of Common Stock
upon the issuance or sale of the Convertible Security. No further adjustment of
the Exercise Price shall be made upon the actual issuance of such shares of
Common Stock upon conversion, exercise or exchange of such Convertible
Securities, and if any such issue or sale of such Convertible Securities is made
upon exercise of any Options for which adjustment of this Warrant has been or is
to be made pursuant to other provisions of this Section 2(a), no further
adjustment of the Exercise Price shall be made by reason of such issue or
sale.

    

                         (iii)
Change in Option Price or Rate of Conversion. If the purchase price provided for
in any Options, the additional consideration, if any, payable upon the issue,
conversion, exercise or exchange of any Convertible Securities, or the rate at
which any Convertible Securities are convertible into or exercisable or
exchangeable for shares of Common Stock increases or decreases at any time, the
Exercise Price and the number of Warrant Shares in effect at the time of such
increase or decrease shall be adjusted to the Exercise Price and the number of
Warrant Shares which would have been in effect at such time had such Options or
Convertible Securities provided for such increased or decreased purchase price,
additional consideration or increased or decreased conversion rate, as the case
may be, at the time initially granted, issued or sold. For purposes of this
Section 2(a)(iii), if the terms of any Option or Convertible Security that was
outstanding as of the date of issuance of this Warrant are increased or
decreased in the manner described in the immediately preceding sentence, then
such Option or Convertible Security and the shares of Common Stock deemed
issuable upon exercise, conversion or exchange thereof shall be deemed to have
been issued as of the date of such increase or decrease. No adjustment pursuant
to this Section 2(a) shall be made if such adjustment would result in an
increase of the Exercise Price then in effect or a decrease in the number of
Warrant Shares.

    

                         (iv)
Calculation of Consideration Received. In case any Option is issued in
connection with the issue or sale of other securities of the Company, together
comprising one integrated transaction in which no specific consideration is
allocated to such Options by the parties thereto, the Options will be
deemed to have been issued for a consideration of $0.01. If any shares of Common
Stock, Options or Convertible Securities are issued or sold or deemed to have
been issued or sold for cash, the consideration received therefore will be
deemed to be the net amount received by the Company therefore. If any shares of
Common Stock, Options or Convertible Securities are issued or sold for a
consideration other than cash, the amount of such consideration received by
the Company will be the fair value of such consideration, except where such
consideration consists of securities, in which case the amount of consideration
received by the Company will be the Closing Sale Price of such security on the
date of receipt. If any shares of Common Stock, Options or Convertible
Securities are issued to the owners of the non-surviving entity in connection
with any merger in which the Company is the surviving entity, the amount of
consideration therefore will be deemed to be the fair value of such portion
of the net assets and business of the non-surviving entity as is attributable to
such shares of Common Stock, Options or Convertible Securities, as the case may
be. The fair value of any consideration other than cash or securities
will be determined jointly by the Company and the Holder. If such parties are
unable to reach agreement within ten days after the occurrence of an event
requiring valuation (the "Valuation Event"), the fair value of such
consideration will be determined within five Business Days after the tenth day
following the Valuation Event by an independent, reputable appraiser selected by
the Holder and approved by the Company. The determination of such appraiser
shall be final and binding upon all parties absent manifest error and the fees
and expenses of such appraiser shall be borne by the Company.

     

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    

                         (v)
Record Date. If the Company takes a record of the  holders of shares
of Common Stock for the purpose of  entitling them (A) to receive a
dividend or other distribution payable in shares of Common Stock, Options
or  in Convertible Securities or (B) to subscribe for
or  purchase shares of Common Stock, Options or Convertible
Securities, then such record date will be deemed to be the date of the issue or
sale of the shares of Common Stock deemed to have been issued or sold upon the
declaration of such dividend or the making of such other distribution
or  the date of the granting of such right of subscription or
purchase, as the case may be.

    

               (b)
Adjustment upon Subdivision or Combination of shares of Common Stock. If the
Company at any time on or after the Closing Date subdivides (by any stock split,
stock dividend, recapitalization or otherwise) one or more classes of its
outstanding shares of Common Stock into a greater number of shares, the Exercise
Price in effect immediately prior to such subdivision will be proportionately
reduced and the number of Warrant Shares will be proportionately increased. If
the Company at any time on or after the Closing Date combines (by
combination, reverse stock split or otherwise) one or more classes of its
outstanding shares of Common Stock into a smaller number of shares, the Exercise
Price in effect immediately prior to such combination will
be proportionately increased and the number of Warrant Shares will be
proportionately decreased. Any adjustment under this Section 2(b) shall become
effective at the close of business on the date the subdivision or combination
becomes effective.

    

                (c)
Other Events. If any event occurs of the type contemplated by the provisions of
this Section 2 but not expressly provided for by such provisions (including,
without limitation, the granting of stock appreciation rights, phantom stock
rights or other rights with equity features), then the Company's Board of
Directors will make an appropriate adjustment in the Exercise Price so as to
protect the rights of the Holder; provided that no such adjustment pursuant to
this Section 2(c) will increase the Exercise Price or decrease the number of
Warrant Shares as otherwise determined pursuant to this Section 2.

    

                Section
3. Rights upon Distribution of Assets. If the Company shall declare or make any
dividend or other distribution of its assets (or rights to acquire its assets)
to holders of shares of Common Stock, by way of return of capital or otherwise
(including, without limitation, any distribution of cash, stock or other
securities, property or options by way of a dividend, spin off,
reclassification, corporate rearrangement, scheme of arrangement or other
similar transaction) (a "Distribution"), at any time after the issuance of this
Warrant, then, in each such case:

    

                (a)
any Exercise Price in effect immediately prior to the close of business on the
record date fixed for the determination of holders of shares of Common Stock
entitled to receive the Distribution shall be reduced, effective as of the close
of business on such record date, to a price determined by multiplying such
Exercise Price by a fraction of which (i) the numerator shall be the Closing Bid
Price of the shares of Common Stock on the trading day immediately preceding
such record date minus the value of the Distribution (as determined in good
faith by the Holder and approved by the Company's Board of Directors)
applicable to one share of Common Stock, and (ii) the denominator shall be the
Closing Bid Price of the shares of Common Stock on the trading day immediately
preceding such record date; and

     

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    

                 (b)
the number of Warrant Shares shall be increased to a number of shares equal to
the number of shares of Common Stock obtainable immediately prior to the close
of business on the record date fixed for the
determination of holders of Common Stock entitled to receive the Distribution
multiplied by the reciprocal of the fraction set forth in the immediately
preceding paragraph (a); provided that in the event that the Distribution is of
shares of or common stock ("Other Shares of Common Stock") of a company
whose common shares are traded on a national securities exchange or a national
automated quotation system, then the Holder may elect to receive a warrant to
purchase Other Shares of Common Stock, the terms of which shall be identical to
those of this Warrant, except that such warrant shall be exercisable into
the number of shares of Other Shares of Common Stock that would have been
payable to the Holder pursuant to the Distribution had the Holder exercised this
Warrant immediately prior to such record date and with an aggregate exercise
price equal to the product of the amount by which the exercise price of this
Warrant was decreased with respect to the Distribution pursuant to the terms of
the immediately preceding paragraph (a), and the number of Warrant Shares
calculated in accordance with the first part of this paragraph (b).

    

             Section
4. Purchase Rights; Fundamental Transactions.

    

                (a)
Purchase Rights. In addition to any adjustments pursuant to Section 2 above, if
at any time the Company grants, issues or sells any Options, Convertible
Securities or rights to purchase stock, warrants, securities or other property
pro rata to the record holders of any class of shares of Common Stock (the
"Purchase Rights"), then the Holder will be entitled to acquire, upon the terms
applicable to such Purchase Rights, the aggregate Purchase Rights which the
Holder could have acquired if the Holder had held the number of shares of Common
Stock acquirable upon complete exercise of this Warrant (without regard to any
limitations on the exercise of this Warrant) immediately before the date on
which a record is taken for the grant, issuance or sale of such Purchase Rights,
or, if no such record is taken, the date as of which the record holders of
shares of Common Stock are to be determined for the grant, issue or sale of such
Purchase Rights.

    

                (b)
Fundamental Transactions. If the Company enters into or is party to a
Fundamental Transaction, then the Holder shall have the right to either (A)
purchase and receive upon the basis and upon the terms and conditions herein
specified and in lieu of the Warrant Shares immediately theretofore issuable
upon exercise of the Warrant, such shares of stock, securities or assets
(including cash) as would have been issuable or payable with respect to or in
exchange for a number of Warrant Shares equal to the number of Warrant Shares
immediately theretofore issuable upon exercise of the Warrant, had such
Fundamental Transaction not taken place or (B) require the repurchase of this
Warrant for a purchase price, payable in cash within five Business Days after
such request, equal to the Black Scholes Value of the remaining unexercised
portion of this Warrant on the date of such request. The terms of any agreement
pursuant to which a Fundamental Transaction is effected shall include terms
requiring any such successor or surviving entity and Holder to comply with the
provisions of this Section 4(b). The provisions of this Section shall apply
similarly and equally to successive Fundamental Transactions and shall be
applied without regard to any limitations on the exercise of this
Warrant.

    

             Section
5. Noncircumvention. The Company hereby covenants and agrees that the Company
will not, by amendment of its Articles of Incorporation, Bylaws or through any
reorganization, transfer of assets, consolidation, merger, scheme of
arrangement, dissolution, issue or sale of securities, or any other voluntary
action, avoid or seek to avoid the observance or performance of any of the terms
of this Warrant, and will at all times in good faith carry out all the
provisions of this Warrant and take all action as may be required to protect the
rights of the Holder. Without limiting the generality of the foregoing, the
Company (i) shall not increase the par value of any shares of Common Stock
receivable upon the exercise of this Warrant above the Exercise Price then in
effect, (ii) shall take all such actions as may be necessary or appropriate in
order that the Company may validly and legally issue fully paid and
nonassessable shares of Common Stock upon the exercise of this Warrant, and
(iii) shall, so long as this Warrant is outstanding, take all action necessary
to reserve and keep available out of its authorized and unissued shares of
Common Stock, solely for the purpose of effecting the exercise of this Warrant,
the number of shares of Common Stock as shall from time to time be necessary to
effect the exercise of this Warrant then outstanding (without regard to any
limitations on exercise).

     

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    

             Section
6. Reservation of Authorized Shares.

    

                (a)
Initial Reservation. Within 60 days of a written demand by the Holder, the
Company shall reserve out of its authorized and unissued Common Stock the number
of shares of Common Stock needed to satisfy a full exercise of this Warrant and
provide to the Holder evidence thereof in form and substance satisfactory to the
Holder.

    

                (b)
Ongoing Reservation. So long as this Warrant is outstanding, the Company shall
take all actions necessary to reserve and keep available out of its authorized
and unissued Common Stock, solely for the purpose of effecting the exercise of
this Warrant, the number of shares of Common Stock as shall at all times after
60 days from a written demand by the Holder and from time to time thereafter as
necessary to effect the exercise of this Warrant; provided that at no time shall
the number of shares of Common Stock so reserved be less than the number of
shares required to be reserved by Section 6(a) hereof (without regard to any
limitations on conversions) (the "Required Reserve Amount").

    

                (c)
Insufficient Authorized Shares. If, at any time after 60 days of a written
demand by the Holder while this Warrant remain outstanding the Company does not
have a sufficient number of authorized and unreserved shares of Common Stock to
satisfy its obligation to reserve for issuance  upon the exercise of
this Warrant at least a number of shares of Common Stock equal to the Required
Reserve Amount (an "Authorized Share Failure"), then the Company shall
immediately take all  action necessary to increase the Company's
authorized shares of Common Stock to an amount sufficient to allow the Company
to reserve the Required Reserve Amount for this Warrant. Without limiting the
generality of the foregoing sentence, as soon as practicable after the date of
the occurrence of an Authorized Share Failure, but in no event later than 60
days after the occurrence of such Authorized Share Failure, the Company shall
hold a meeting of its stockholders for the approval of an increase in the number
of authorized shares of Common Stock. In connection with such meeting, the
Company shall provide each stockholder with a proxy statement and shall use its
best efforts to solicit its stockholders' approval of such increase in
authorized shares of Common Stock and to cause its Board of Directors to
recommend to the stockholders that they approve such proposal.

    

             Section
7. Warrant Holder not Deemed a Stockholder. Except as otherwise specifically
provided herein, the Holder, solely in such Person's capacity as a holder of
this Warrant, shall not be entitled to vote or receive dividends or be deemed
the holder of share capital of the Company for any purpose, nor shall anything
contained in this Warrant be construed to confer upon the Holder, solely in such
Person's capacity as the Holder of this Warrant, any of the rights of a
shareholder of the Company or any right to vote, give or withhold consent to any
corporate action (whether any reorganization, issue of stock, reclassification
of stock, consolidation, merger, conveyance or otherwise), receive notice of
meetings, receive dividends or subscription rights, or otherwise, prior to the
issuance to the Holder of the Warrant Shares which such Person is then entitled
to receive upon the due exercise of this Warrant. In addition, nothing contained
in this Warrant shall be construed as imposing any liabilities on the Holder to
purchase any securities (upon exercise of this Warrant or otherwise) or as a
shareholder of the Company, whether such liabilities are asserted by the Company
or by creditors of the Company. Notwithstanding this Section 7, the Company
shall provide the Holder with copies of the same notices and other information
given to the shareholders of the Company generally, contemporaneously with the
giving thereof to the shareholders.

    

             Section
8. Reissuance of Warrants.

     

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    

                (a)
Transfer of Warrant. If this Warrant is to be transferred, the Holder shall
surrender this Warrant to the Company, whereupon the Company will forthwith
issue and deliver upon the order of the Holder a new Warrant (in accordance with
Section 8(d)), registered as the Holder may request.

    

                (b)
Lost, Stolen or Mutilated Warrant. Upon receipt by the Company of evidence
reasonably satisfactory to the Company of the loss, theft, destruction or
mutilation of this Warrant, and, in the case of loss, theft or destruction, of
any indemnification undertaking by the Holder to the Company in customary form
and, in the case of mutilation, upon surrender and cancellation of this
Warrant, the Company shall execute and deliver to the Holder a new Warrant (in
accordance with Section 8(d)).

    

                (c)
Exchangeable for Multiple Warrants. This Warrant is exchangeable, upon the
surrender hereof by the Holder at the principal office of the Company, for a new
Warrant or Warrants (in accordance with Section 8(d)) representing in the
aggregate the right to purchase the number of Warrant Shares then
underlying this Warrant, and each such new Warrant will represent the right to
purchase such portion of such Warrant Shares as is designated by the Holder at
the time of such surrender; provided, however, that no Warrants for fractional
shares of Common Stock shall be given.

    

                (d)
Issuance of New Warrants. Whenever the Company is required to issue a new
Warrant pursuant to the terms of this Warrant, such new Warrant (i) shall be of
like tenor with this Warrant, (ii) shall represent, as indicated on the face of
such new Warrant, the right to purchase the Warrant Shares then underlying this
Warrant (or in the case of a new Warrant being issued pursuant to Section 8(a)
or Section 8(c), the Warrant Shares designated by the
Holder  which,  when added to the number of shares of Common
Stock  underlying the other new Warrants issued in connection with
such issuance, does not exceed the number of Warrant Shares
then  underlying  this Warrant),  (iii) shall have
an issuance date,  as  indicated  on the face of
such new  Warrant  which is the same as the
Closing  Date,  and (iv)  shall  have
the same  rights  and  conditions  as
this Warrant.

    

             Section
9. Notices. Whenever notice is required to be given under this Warrant, unless
otherwise provided herein, such notice shall be given in accordance with Section
7 of the Agreement. The Company shall provide the Holder with prompt written
notice of all actions taken pursuant to this Warrant, including in reasonable
detail a description of such action and the reason therefor. Without limiting
the generality of the foregoing, the Company will give written notice to the
Holder (i) immediately upon any adjustment of the Exercise Price, setting
forth in reasonable detail, and certifying, the calculation of such
adjustment and (ii) at least fifteen days prior to the date on which the Company
closes its books or takes a record (A) with respect to any dividend or
distribution upon the shares of Common Stock, (B) with respect to any grants,
issuances or sales of any Options, Convertible Securities or rights to purchase
stock, warrants, securities or other property to holders of shares of Common
Stock or (C) for determining rights to vote with respect to any Fundamental
Transaction, dissolution or liquidation, provided in each case that such
information shall be made known to the public prior to or in conjunction with
such notice being provided to the Holder.

    

             Section
10. Amendment and Waiver. Except as otherwise provided herein, the provisions of
this Warrant may be amended and the Company may take any action herein
prohibited, or omit to perform any act herein required to be performed by it,
only if the Company has obtained the prior written consent of the Holder;
provided that no such action may increase the Exercise Price of this Warrant or
decrease the number of shares or class of stock obtainable upon exercise of this
Warrant.

    

             Section
11. Severability. If any provision of this Warrant or the application thereof
becomes or is declared by a court of competent jurisdiction to be illegal, void
or unenforceable, the remainder of the terms of this Warrant will continue in
full force and effect.

     

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    

             Section
12. Governing Law; Jurisdiction; Jury Trial. All questions concerning the
construction, validity, enforcement and interpretation of this Warrant shall be
governed by the internal laws of the State of New York, without giving effect to
any choice of law or conflict of law provision or rule (whether of the State of
New York or any other jurisdictions) that would cause the application of the
laws of any jurisdictions other than the State of New York. Each party hereby
irrevocably submits to the exclusive jurisdiction of the state and federal
courts sitting in The City of New York, Borough of Manhattan, for the
adjudication of any dispute hereunder or in connection herewith or with any
transaction contemplated hereby or discussed herein, and hereby irrevocably
waives, and agrees not to assert in any suit, action or proceeding, any
claim that it is not personally subject to the jurisdiction of any such court,
that such suit, action or proceeding is brought in an inconvenient forum or that
the venue of such suit, action or proceeding is improper. Each party hereby
irrevocably waives personal service of process and consents to process being
served in any such suit, action or proceeding by mailing a copy thereof to such
party at the address for such notices to it under this Warrant and agrees that
such service shall constitute good and sufficient service of process and notice
thereof. Nothing contained herein shall be deemed to limit in any way any right
to serve process in any manner permitted by law. EACH PARTY HEREBY IRREVOCABLY
WAIVES ANY RIGHT IT MAY HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE
ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF
ANY TRANSACTION CONTEMPLATED HEREBY.

    

             Section
13. Construction; Headings. This Warrant shall be deemed to be jointly drafted
by the Company and the Holder and shall not be construed against any person as
the drafter hereof. The headings of this Warrant are for convenience of
reference and shall not form part of, or affect the interpretation of,
this Warrant.

    

             Section
14. Dispute Resolution. In the case of a dispute as to the determination of the
Exercise Price or the arithmetic calculation of the Warrant Shares, the Company
shall submit the disputed determinations or arithmetic calculations within two
Business Days of receipt of the Exercise Notice giving rise to such dispute, as
the case may be, to the Holder. If the Holder and the Company are unable to
agree upon such determination or calculation of the Exercise Price or the
Warrant Shares within one Business Day of such disputed determination or
arithmetic calculation being submitted to the Holder, then the Company shall,
within one Business Day submit (a) the disputed determination of the Exercise
Price to an independent, reputable investment bank selected by the Holder and
approved by the Company or (b) the disputed arithmetic calculation of the
Warrant Shares to an independent, reputable accounting firm selected by the
Holder and approved by the Company. The Company shall cause, at its expense, the
investment bank or the accounting firm, as the case may be, to perform the
determinations or calculations and notify the Company and the Holder of the
results no later than five Business Days from the date it receives the disputed
determinations or calculations. Such investment bank's or accountant's
determination or calculation, as the case may be, shall be binding upon all
parties absent demonstrable error.

    

             Section
15. Remedies, Other Obligations, Breaches and Injunctive Relief. The remedies
provided in this Warrant shall be cumulative and in addition to all other
remedies available under this Warrant, at law or in equity (including a decree
of specific performance and/or other injunctive relief), and nothing herein
shall limit the right of the Holder to seek actual damages for any failure by
the Company to comply with the terms of this Warrant. The Company acknowledges
that a breach by it of its obligations hereunder will cause irreparable
harm to the Holder and that the remedy at law for any such breach may be
inadequate. The Company therefore agrees that, in the event of any such breach
or threatened breach, the holder of this Warrant shall be entitled, in
addition to all other available remedies, to an injunction restraining any
breach, without the necessity of showing economic loss and without any bond or
other security being required.

     

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    

             Section
16. Transfer. This Warrant may be offered for sale, sold, transferred or
assigned without the consent of the Company.

    

             Section
17.  Certain  Definitions.  For purposes of this
Warrant, the following terms shall have the following meanings:

    

              "Affiliate"
means, as to any Person, any other Person which directly or indirectly controls,
is controlled by, or is under common control with such Person. For purposes of
this definition, "control" of a Person includes (A) the power, direct or
indirect, (i) to vote or direct the voting of 10% or more of the outstanding
shares of Voting Stock of such Person, or (ii) to direct or cause the direction
of the management and policies of such Person (whether by ownership of Capital
Stock, by contract or otherwise) or (B) the ownership of Capital Stock or other
securities representing 10% or more of the total economic interests of such
Person; provided, that the Holder shall be deemed to be an Affiliate of the
Company.

    

                "Aggregate
Exercise Price" has the meaning set forth in Section 1(a).

    

                "Applicable
Price" has the meaning set forth in Section 2(a).

    

                "Approved
Stock Plan" means any employee benefit plan which has been approved by the Board
of Directors of the Company, pursuant to which the Company's securities may be
issued to any employee, officer or director for services provided to the
Company.

    

                "Authorized  Share  Failure"  has
the  meaning  set forth in Section 6(b).

    

                "Black
Scholes Value" means the value of this Warrant based on the Black and Scholes
Option Pricing Model obtained from the "OV" function on Bloomberg determined as
of the day immediately following the public announcement of the applicable
Fundamental Transaction and reflecting (i) a risk-free interest rate
corresponding to the U.S. Treasury rate for a period equal to the remaining term
of this Warrant as of such date of request is 2.5% and (ii) an expected
volatility equal to 60%.

    

                "Bloomberg"
means Bloomberg Financial Markets.

    

                "Business
Day" means any day other than Saturday, Sunday or other day on which commercial
banks in The City of New York, New York are authorized or required by law to
remain closed.

    

                "Buy-In
Price" has the meaning set forth in Section 1(c).

    

                "Capital
Stock" means and includes, with respect to any Person (a) any and all shares,
interests, participations or other equivalents of or interests in (however
designated) corporate stock, including shares of preferred or preference stock
of such Person, (b) all partnership interests (whether general or limited) in
such Person which is a partnership, (c) all membership interests or limited
liability company interests in such Person which is a limited liability company,
(d) any interest or participation that confers on a Person the right to receive
a share of the profits and/or losses of, or distributions of assets of such
Person, and (e) all equity or ownership interests in such Person of any other
type, and any and all warrants, rights or options to purchase any of the
foregoing.

    

                "Cash
Exercise" has the meaning set forth in Section 1(d).

    

                "Cashless
Exercise" has the meaning set forth in Section 1(d).

     

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    

                 "Closing
Bid Price" and "Closing Sale Price" means, for any security as of any date, the
last closing bid price and last closing trade price, respectively, for such
security on the Principal Market, as reported by Bloomberg, or, if the Principal
Market begins to operate on an extended hours basis and does not designate the
closing bid price or the closing trade price, as the case may be, then the last
bid price or last trade price, respectively, of such security prior to 4:00:00
p.m., New York time, as reported by Bloomberg, or, if the Principal Market is
not the principal securities exchange or trading market for such security, the
last closing bid price or last trade price, respectively, of such security on
the principal securities exchange or trading market where such security is
listed or traded as reported by Bloomberg, or if the foregoing do not
apply, the last closing bid price or last trade price, respectively, of such
security in the over-the-counter market on the electronic bulletin board for
such security as reported by Bloomberg, or, if no closing bid price or last
trade price, respectively, is reported for such security by Bloomberg, the
average of the bid prices, or the ask prices, respectively, of any market makers
for such security as reported in the "pink sheets" by Pink Sheets LLC (formerly
the National Quotation Bureau, Inc.). If the Closing Bid Price or the Closing
Sale Price cannot be calculated for a security on a particular date on any of
the foregoing bases, the Closing Bid Price or the Closing Sale Price, as the
case may be, of such security on such date shall be the fair market value as
mutually determined by the Company and the Holder. If the Company and the Holder
are unable to agree upon the fair market value of such security, then such
dispute shall be resolved in the same manner as the disputes described in
Section 14. All such determinations to be appropriately adjusted for any stock
dividend, stock split, stock combination or other similar transaction during the
applicable calculation period.

    

                "Closing
Date" has the meaning set forth in the preamble to this Warrant.

    

                "Common
Stock" means (i) the Company's shares of common stock, $0.001 par value per
share, and (ii) any share capital into which such common stock shall have been
changed or any share capital resulting from a reclassification of such common
stock.

    

                "Company"
has the meaning set forth in the preamble to this Warrant.

    

                "Convertible
Securities" means any stock or securities (other than Options) directly or
indirectly convertible into or exercisable or exchangeable for shares of Common
Stock.

    

                "Dilutive
Issuance" has the meaning set forth in Section 2(a).

    

                "Distribution"
has the meaning set forth in Section 3.

    

                "DTC"
has the meaning set forth in Section 1(a).

    

                "Excluded
Security" means any Common Stock issued or issuable: (i) in connection with any
Approved Stock Plan; (ii) upon conversion of any Preferred Stock or this
exercise of the Warrant; and (iii) upon conversion of any Options or Convertible
Securities which are outstanding on the day immediately preceding the Closing
Date, provided that the terms of each such Options or Convertible Securities are
not amended, modified or changed on or after the Closing Date.

    

                 "Exercise
Delivery Documents" has the meaning set forth in Section 1(a).

    

                "Exercise
Price" has the meaning set forth in Section 1(b).

    

                "Exercise
Notice" has the meaning set forth in Section 1(a).

     

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    

                "Expiration
Date" means the date three year after the Closing Date or, if such date falls on
a day other than a Business Day or on which trading does not take place on the
Principal Market (a "Holiday"), the next date that is not a
Holiday.

    

                "Fundamental
Transaction" means that the Company shall, directly or indirectly, in one or
more related transactions, (i) consolidate or merge with or into (whether or not
the Company is the surviving corporation) another Person, or (ii) sell, assign,
transfer, convey or otherwise dispose of all or substantially all of the
properties or assets of the Company to another Person, or (iii) allow another
Person to make a purchase, tender or exchange offer that is accepted by the
holders of more than the 50% of either the outstanding shares of Common
Stock (not including any shares of Common Stock held by the Person or Persons
making or party to, or associated or affiliated with the Persons making or party
to, such purchase, tender or exchange offer), or (iv) consummate a stock
purchase agreement or other business combination (including, without limitation,
a reorganization, recapitalization, spin-off or scheme of arrangement) with
another Person whereby such other Person acquires more than the 50% of the
outstanding shares of Common Stock (not including any shares of Common Stock
held by the other Person or other Persons making or party to, or associated or
affiliated with the other Persons making or party to, such stock purchase
agreement or other business combination), or (v) reorganize, recapitalize or
reclassify its Common Stock.

    

                "Holder"
has the meaning set forth in the preamble to this Warrant.

    

                "New
Issuance Price" has the meaning set forth in Section 2(a).

    

                "Maximum
Percentage" has the meaning set forth in Section 1(f).

    

                "Consulting
Agreement" has the meaning set forth in the preamble to this
Warrant.

    

                "Options"
means any rights, warrants or options to subscribe for or purchase shares of
Common Stock or Convertible Securities.

    

                "Other
Shares of Common Stock" has the meaning set forth in Section 3(b).

    

                 "Person"
means an individual, a limited liability company, a partnership, a joint
venture, a corporation, a trust, an unincorporated organization, any other
entity and a government or any department or agency thereof.

    

                "Principal
Market" means the NASD OTC Bulletin Board.

    

                "Purchase
Rights" has the meaning set forth in Section 4(a).

    

                "Registration
Rights Agreement" means that certain Registration Rights Agreement, dated as of
even date herewith, by and among the Company and the Holder.

    

                "Required
Reserve Amount" has the meaning set forth in Section 6(a).

    

                "Transfer
Agent" has the meaning set forth in Section 1(a).

    

                "Valuation
Event" has the meaning set forth in Section 2(a)(iv).

     

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    

                "Voting
Stock" means, with respect to any Person, the Capital Stock of such Person of
any class or classes, the holders of which are ordinarily, in the absence of
contingencies, entitled to vote for the election of members of the Board of
Directors (or Persons performing similar functions) of such Person.

    

                "Warrant"
has the meaning set forth in the preamble to this Warrant.

    

                "Warrant
Shares" has the meaning set forth in the preamble to this Warrant.

    

    

    

                                [Signature
Page Follows]

    

    

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    
 

             IN
WITNESS WHEREOF, the Company has caused this Warrant to Purchase Common Stock to
be duly executed as of the Date of Issuance set out above.

     

    
      	 	      
              PREVENTION
      INSURANCE.COM, INC.

              

              By:    __________________________

              Name:
      Alan P. Donenfeld

              Title:   CEO

            

    

     

    

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    

     

    EXHIBIT
A

    

    EXERCISE
NOTICE

    TO BE
EXECUTED BY THE REGISTERED HOLDER TO EXERCISE THIS

    WARRANT
TO PURCHASE COMMON STOCK

    

    PREVENTION
INSURANCE.COM, INC.

    

    The
undersigned holder hereby exercises the right to purchase _________________ of
the shares of Common Stock ("Warrant Shares") of PREVENTION INSURANCE.COM, INC.,
a Nevada corporation (the "Company"), evidenced by the attached Warrant to
Purchase Common Stock (the "Warrant"). Capitalized terms used herein and not
otherwise defined shall have the respective meanings set forth in the
Warrant.

    

             1.
Form of Exercise  Price.  The Holder intends that payment of
the Exercise Price shall be made as:

    

                ____________
a "Cash Exercise" with respect to _________________ Warrant Shares;
and/or

    

                ____________
a "Cashless Exercise" with respect to ____________ Warrant Shares.

    

              2.
Payment of Exercise Price. In the event that the holder has elected a Cash
Exercise with respect to some or all of the Warrant Shares to be issued pursuant
hereto, the holder shall pay the Aggregate Exercise Price in the sum of
$___________________ to the Company in accordance with the terms of the
Warrant.

    

             
3. Delivery of Warrant Shares. The Company shall deliver to the holder
__________ Warrant Shares in accordance with the terms of the
Warrant.

    

    Date:
_______________ __, ______

    

     ________________________________

    Name
of  Holder

    

    By:______________________________

    

    Name:____________________________

    

    Title:___________________________

    

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    

     

    ACKNOWLEDGMENT

    

              The
Company hereby acknowledges this Exercise Notice and hereby directs OTR to issue
the above indicated number of shares of Common Stock in accordance with the
Transfer Agent Instructions from the Company and acknowledged and agreed to by
OTR.

     

    
      	 	      
              PREVENTION
      INSURANCE.COM, INC.

              

              By:
      __________________________

              Name:
      Alan P. Donenfeld

              Title:   CEOf10q0708ex10iii_previns.htm

    PARAGON
CAPITAL LP

    110
EAST 59TH STREET, 29TH FL NEW YORK, NY 10022

    (212)
593-1600

    

    August
12, 2008

    

    Mr. Scott
Goldsmith

    2770 So.
Maryland Pkwy.

    Las
Vegas, NV 89109

    

    Dear Mr.
Goldsmith:

    

    The
following sets forth a clarification of and an addendum to the Schedule A
agreement (the "Agreement") between Paragon. Capital LP ("Paragon"), Scott
Goldsmith ("Goldsmith") and Prevention Insurance.com
Inc. (the "Company" or "Prevention") dated December 28, 2007.

    

    
      	
              1.

            	
              In
      accordance with the Stock Purchase Agreement dated December 31, 2007,
      Paragon paid Prevention a total of $250,000 for a total of 71,428,571
      shares of the Company. Prevention paid to Goldsmith $200,000 to an account
      designated by Goldsmith under the name Quick. Pay. All assets and
      liabilities (including the payment to Goldsmith of $200,000 or remainder
      thereof) of the Quick Pay businP.ss will remain on the balance sheet of
      Prevention„ until the date that Prevention conveys all of the assets and
      liabilities of Quick Pay to Goldsmith, which will not be later than
      October 31, 2008. The payment of the $200,000 to Goldsmith, which has
      already occurred, and the conveyance of the assets and liabilities of
      Quick Pay to Goldsmith shall be in consideration for the cancellation of
      all of the issued and outstanding shares of preferred stock, warrants and
      liabilities held by Goldsmith. Such cancellation of the preferred,
      warrants and liabilities has been
completed.

            

    

    

    
      	
              2.

            	
              Paragon
      agrees that on the date of the Quick Pay conveyance it will assign
      warrants to Goldsmith to acquire 5,000,000 shares of common stock (which
      will replace the 4,000,000 warrants referred to in the Agreement)
      exercisable over a 3 year term and with an exercise price of $0.01. These
      warrants and underlying shares of common stock are subject to usual
      dilution for any stock split or other stock
  subdivision.

            

    

    

    
      	
              3.

            	
              The
      Company agrees that the $400,000 amount to be paid to Goldsmith shall be
      for the above consideration. The $400,000 payment owed to Mr. Goldsmith
      shall be payable upon the earlier of (i) such time as the Company has
      completed a PIPE financing of at least $2,000,000 or (ii) such time as the
      Company completes a reverse merger transaction, or (iii) eighteen months
      from the date of the original agreement dated December 28, 2007 Scheduled
      A. In the absence of (i) (ii) or (iii) Prevention will have the right to
      require Goldsmith to convert the $400,000 payment into 1,600,000 common
      shares, non dilutable for stock splits for a period from 4 yrs from the
      date of the issuance of the stock. with piggy back registration rights any
      time he chooses. This right expires September 30th  2009.

            

    

     

     

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

     

     

    
      	
              4.

            	
              All
      notices, requests and instructions hereunder shall be in writing and
      delivered to each party at the addresses set forth above or to such other
      address as may from time to time be designated by a party
      hereto.

            

    

    

    
      	
              5.

            	
              In
      the event that any term, covenant, condition, or other provision contained
      herein is held to be invalid, void or otherwise unenforceable by any court
      of competent jurisdiction, the invalidity of any such term, covenant,
      condition, provision or agreement shall in no way affect any other term,
      covenant, condition or provision or agreement contained herein, which
      shall remain in full force and
effect.

            

    

    

    
      	
              6.

            	
              This
      Agreement contains all of the terms agreed upon by the parties with taped
      to the subject matter hereof. This Agreement has been catered into after
      full investigation.

            

    

    

    
      	
              7.

            	
              This
      Agreement shall be construed in accordance with and governed by the laws
      of the State of New York applicable to agreements made and to be performed
      within the State of New York without giving the effect to the conflict of
      law principals thereof.

            

    

    

    
      	
              8.

            	
              Goldsmith
      shall retain the name prevention
insurance.

            

    

    

    
      	
              9.

            	
              Should
      the Quick pay spin off to Goldsmith exceed October 31, 2008 a penalty fee
      of $10,000 will be paid to
Goldsmith

            

    

    

    
      	
              10.

            	
              No
      amendments or additions to this Agreement shall be binding unless in
      writing, signed by both parties, except as herein otherwise
      provided.

            

    

    

    Please
sign below to acknowledge the acceptance of the terms of this
Agreement.

    Very
truly yours,

    

    PARAGON
CAPITAL LP

    By:  /s/  Alan
Donenfeld        

    ALAN
DONENFELD

    Managing
Member of Paragon Capital Advisors LLC,

    General
Partner of Paragon Capital LP

    

    ACCEPTED
AND AGREED TO BY:

    By:  /s/  Scott
Goldsmith        

    SCOTT
GOLDSMITH

    

    ACCEPTED
AND AGREED TO BY:

    By:  /s/  Alan
Donenfeld        

    ALAN P.
DONENFELD

    President

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00147-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00147-of-00352.parquet"}]]